Therapeutic area intelligence for Obsessive-Compulsive Disorder (OCD) with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.

Signals: 1
Catalysts: 0
Companies: 0

Companies

No related entities indexed yet.

Assets

Medtronic →

Recent signals(1)

ClinicalJuly 25, 2026

Neurophysiological Study on DBS in OCD Patients to Inform Neuromodulation Strategies

A clinical trial is underway to investigate the neurophysiological mechanisms in OCD patients using deep brain stimulation (DBS) with Medtronic's technology.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

Obsessive-Compulsive Disorder (OCD) →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.